Global Human Chorionic Gonadotropin (HCG) Market Insights and Forecast to 2028

Publisher Name :
Date: 21-Feb-2022
No. of pages: 106
Inquire Before Buying

Human Chorionic Gonadotropin (HCG) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Human Chorionic Gonadotropin (HCG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Natural Source Extraction

- Recombinant DNA Technology

Segment by Application

- Female Infertility Treatment

- Oligospermic Treatment

- Cryptorchidism Treatment

- Others

By Company

- EMD Serono, Inc

- Ferring B.V

- Merck & Co., Inc

- Bristol Myers Squibb Company

- Fresenius Kabi AG, LLC

- Scrippslabs

- Leebio

- Kamiya Biomedical Company

- Sanzyme

- Cigna

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Global Human Chorionic Gonadotropin (HCG) Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Human Chorionic Gonadotropin (HCG) Product Introduction
1.2 Market by Type
1.2.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Natural Source Extraction
1.2.3 Recombinant DNA Technology
1.3 Market by Application
1.3.1 Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Female Infertility Treatment
1.3.3 Oligospermic Treatment
1.3.4 Cryptorchidism Treatment
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Human Chorionic Gonadotropin (HCG) Sales Estimates and Forecasts 2017-2028
2.2 Global Human Chorionic Gonadotropin (HCG) Revenue Estimates and Forecasts 2017-2028
2.3 Global Human Chorionic Gonadotropin (HCG) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Human Chorionic Gonadotropin (HCG) Sales by Region
2.4.1 Global Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2022)
2.4.2 Global Sales Human Chorionic Gonadotropin (HCG) by Region (2023-2028)
2.5 Global Human Chorionic Gonadotropin (HCG) Revenue by Region
2.5.1 Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2022)
2.5.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturers
3.1.1 Global Top Human Chorionic Gonadotropin (HCG) Manufacturers by Sales (2017-2022)
3.1.2 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Chorionic Gonadotropin (HCG) in 2021
3.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers
3.2.1 Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2017-2022)
3.2.2 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Human Chorionic Gonadotropin (HCG) Revenue in 2021
3.3 Global Human Chorionic Gonadotropin (HCG) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Human Chorionic Gonadotropin (HCG) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Chorionic Gonadotropin (HCG) Sales by Type
4.1.1 Global Human Chorionic Gonadotropin (HCG) Historical Sales by Type (2017-2022)
4.1.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Sales by Type (2023-2028)
4.1.3 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2017-2028)
4.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Type
4.2.1 Global Human Chorionic Gonadotropin (HCG) Historical Revenue by Type (2017-2022)
4.2.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Type (2017-2028)
4.3 Global Human Chorionic Gonadotropin (HCG) Price by Type
4.3.1 Global Human Chorionic Gonadotropin (HCG) Price by Type (2017-2022)
4.3.2 Global Human Chorionic Gonadotropin (HCG) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Human Chorionic Gonadotropin (HCG) Sales by Application
5.1.1 Global Human Chorionic Gonadotropin (HCG) Historical Sales by Application (2017-2022)
5.1.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Sales by Application (2023-2028)
5.1.3 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2017-2028)
5.2 Global Human Chorionic Gonadotropin (HCG) Revenue by Application
5.2.1 Global Human Chorionic Gonadotropin (HCG) Historical Revenue by Application (2017-2022)
5.2.2 Global Human Chorionic Gonadotropin (HCG) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Application (2017-2028)
5.3 Global Human Chorionic Gonadotropin (HCG) Price by Application
5.3.1 Global Human Chorionic Gonadotropin (HCG) Price by Application (2017-2022)
5.3.2 Global Human Chorionic Gonadotropin (HCG) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Human Chorionic Gonadotropin (HCG) Market Size by Type
6.1.1 North America Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
6.1.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
6.2 North America Human Chorionic Gonadotropin (HCG) Market Size by Application
6.2.1 North America Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
6.2.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
6.3 North America Human Chorionic Gonadotropin (HCG) Market Size by Country
6.3.1 North America Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2028)
6.3.2 North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Human Chorionic Gonadotropin (HCG) Market Size by Type
7.1.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
7.1.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
7.2 Europe Human Chorionic Gonadotropin (HCG) Market Size by Application
7.2.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
7.2.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
7.3 Europe Human Chorionic Gonadotropin (HCG) Market Size by Country
7.3.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2028)
7.3.2 Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Size by Type
8.1.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
8.1.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
8.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Size by Application
8.2.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
8.2.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
8.3 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Size by Region
8.3.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2028)
8.3.2 Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Type
9.1.1 Latin America Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
9.1.2 Latin America Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
9.2 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Application
9.2.1 Latin America Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
9.2.2 Latin America Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
9.3 Latin America Human Chorionic Gonadotropin (HCG) Market Size by Country
9.3.1 Latin America Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2028)
9.3.2 Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size by Type
10.1.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2028)
10.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size by Application
10.2.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2028)
10.3 Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size by Country
10.3.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 EMD Serono, Inc
11.1.1 EMD Serono, Inc Corporation Information
11.1.2 EMD Serono, Inc Overview
11.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 EMD Serono, Inc Recent Developments
11.2 Ferring B.V
11.2.1 Ferring B.V Corporation Information
11.2.2 Ferring B.V Overview
11.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Ferring B.V Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ferring B.V Recent Developments
11.3 Merck & Co., Inc
11.3.1 Merck & Co., Inc Corporation Information
11.3.2 Merck & Co., Inc Overview
11.3.3 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck & Co., Inc Recent Developments
11.4 Bristol Myers Squibb Company
11.4.1 Bristol Myers Squibb Company Corporation Information
11.4.2 Bristol Myers Squibb Company Overview
11.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bristol Myers Squibb Company Recent Developments
11.5 Fresenius Kabi AG, LLC
11.5.1 Fresenius Kabi AG, LLC Corporation Information
11.5.2 Fresenius Kabi AG, LLC Overview
11.5.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fresenius Kabi AG, LLC Recent Developments
11.6 Scrippslabs
11.6.1 Scrippslabs Corporation Information
11.6.2 Scrippslabs Overview
11.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Scrippslabs Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Scrippslabs Recent Developments
11.7 Leebio
11.7.1 Leebio Corporation Information
11.7.2 Leebio Overview
11.7.3 Leebio Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Leebio Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Leebio Recent Developments
11.8 Kamiya Biomedical Company
11.8.1 Kamiya Biomedical Company Corporation Information
11.8.2 Kamiya Biomedical Company Overview
11.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Kamiya Biomedical Company Recent Developments
11.9 Sanzyme
11.9.1 Sanzyme Corporation Information
11.9.2 Sanzyme Overview
11.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanzyme Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanzyme Recent Developments
11.10 Cigna
11.10.1 Cigna Corporation Information
11.10.2 Cigna Overview
11.10.3 Cigna Human Chorionic Gonadotropin (HCG) Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Cigna Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Cigna Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Chorionic Gonadotropin (HCG) Industry Chain Analysis
12.2 Human Chorionic Gonadotropin (HCG) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Chorionic Gonadotropin (HCG) Production Mode & Process
12.4 Human Chorionic Gonadotropin (HCG) Sales and Marketing
12.4.1 Human Chorionic Gonadotropin (HCG) Sales Channels
12.4.2 Human Chorionic Gonadotropin (HCG) Distributors
12.5 Human Chorionic Gonadotropin (HCG) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Human Chorionic Gonadotropin (HCG) Industry Trends
13.2 Human Chorionic Gonadotropin (HCG) Market Drivers
13.3 Human Chorionic Gonadotropin (HCG) Market Challenges
13.4 Human Chorionic Gonadotropin (HCG) Market Restraints
14 Key Findings in The Global Human Chorionic Gonadotropin (HCG) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Natural Source Extraction
Table 3. Major Manufacturers of Recombinant DNA Technology
Table 4. Global Human Chorionic Gonadotropin (HCG) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Human Chorionic Gonadotropin (HCG) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2022) & (K Units)
Table 7. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2017-2022)
Table 8. Global Human Chorionic Gonadotropin (HCG) Sales by Region (2023-2028) & (K Units)
Table 9. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2023-2028)
Table 10. Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2017-2022)
Table 12. Global Human Chorionic Gonadotropin (HCG) Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region (2023-2028)
Table 14. Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Human Chorionic Gonadotropin (HCG) Sales Share by Manufacturers (2017-2022)
Table 16. Global Human Chorionic Gonadotropin (HCG) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2017-2022)
Table 18. Human Chorionic Gonadotropin (HCG) Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Human Chorionic Gonadotropin (HCG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Human Chorionic Gonadotropin (HCG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2021)
Table 21. Human Chorionic Gonadotropin (HCG) Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Human Chorionic Gonadotropin (HCG) Product Offered
Table 23. Date of Manufacturers Enter into Human Chorionic Gonadotropin (HCG) Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
Table 26. Global Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
Table 27. Global Human Chorionic Gonadotropin (HCG) Sales Share by Type (2017-2022)
Table 28. Global Human Chorionic Gonadotropin (HCG) Sales Share by Type (2023-2028)
Table 29. Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Type (2017-2022)
Table 32. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Type (2023-2028)
Table 33. Human Chorionic Gonadotropin (HCG) Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Human Chorionic Gonadotropin (HCG) Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
Table 36. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
Table 37. Global Human Chorionic Gonadotropin (HCG) Sales Share by Application (2017-2022)
Table 38. Global Human Chorionic Gonadotropin (HCG) Sales Share by Application (2023-2028)
Table 39. Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Application (2017-2022)
Table 42. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Application (2023-2028)
Table 43. Human Chorionic Gonadotropin (HCG) Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Human Chorionic Gonadotropin (HCG) Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
Table 46. North America Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
Table 47. North America Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
Table 50. North America Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
Table 51. North America Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)
Table 54. North America Human Chorionic Gonadotropin (HCG) Sales by Country (2023-2028) & (K Units)
Table 55. North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Human Chorionic Gonadotropin (HCG) Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
Table 58. Europe Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
Table 59. Europe Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
Table 62. Europe Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
Table 63. Europe Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)
Table 66. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2023-2028) & (K Units)
Table 67. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Human Chorionic Gonadotropin (HCG) Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Human Chorionic Gonadotropin (HCG) Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Human Chorionic Gonadotropin (HCG) Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Human Chorionic Gonadotropin (HCG) Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Human Chorionic Gonadotropin (HCG) Revenue by Country (2023-2028) & (US$ Million)
Table 105. EMD Serono, Inc Corporation Information
Table 106. EMD Serono, Inc Description and Major Businesses
Table 107. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. EMD Serono, Inc Recent Developments
Table 110. Ferring B.V Corporation Information
Table 111. Ferring B.V Description and Major Businesses
Table 112. Ferring B.V Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Ferring B.V Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Ferring B.V Recent Developments
Table 115. Merck & Co., Inc Corporation Information
Table 116. Merck & Co., Inc Description and Major Businesses
Table 117. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Merck & Co., Inc Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Merck & Co., Inc Recent Developments
Table 120. Bristol Myers Squibb Company Corporation Information
Table 121. Bristol Myers Squibb Company Description and Major Businesses
Table 122. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Bristol Myers Squibb Company Recent Developments
Table 125. Fresenius Kabi AG, LLC Corporation Information
Table 126. Fresenius Kabi AG, LLC Description and Major Businesses
Table 127. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Fresenius Kabi AG, LLC Recent Developments
Table 130. Scrippslabs Corporation Information
Table 131. Scrippslabs Description and Major Businesses
Table 132. Scrippslabs Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Scrippslabs Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Scrippslabs Recent Developments
Table 135. Leebio Corporation Information
Table 136. Leebio Description and Major Businesses
Table 137. Leebio Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Leebio Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Leebio Recent Developments
Table 140. Kamiya Biomedical Company Corporation Information
Table 141. Kamiya Biomedical Company Description and Major Businesses
Table 142. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Kamiya Biomedical Company Recent Developments
Table 145. Sanzyme Corporation Information
Table 146. Sanzyme Description and Major Businesses
Table 147. Sanzyme Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Sanzyme Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Sanzyme Recent Developments
Table 150. Cigna Corporation Information
Table 151. Cigna Description and Major Businesses
Table 152. Cigna Human Chorionic Gonadotropin (HCG) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 153. Cigna Human Chorionic Gonadotropin (HCG) Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Cigna Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Human Chorionic Gonadotropin (HCG) Distributors List
Table 158. Human Chorionic Gonadotropin (HCG) Customers List
Table 159. Human Chorionic Gonadotropin (HCG) Market Trends
Table 160. Human Chorionic Gonadotropin (HCG) Market Drivers
Table 161. Human Chorionic Gonadotropin (HCG) Market Challenges
Table 162. Human Chorionic Gonadotropin (HCG) Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Chorionic Gonadotropin (HCG) Product Picture
Figure 3. Global Human Chorionic Gonadotropin (HCG) Market Share by Type in 2021 & 2028
Figure 3. Natural Source Extraction Product Picture
Figure 4. Recombinant DNA Technology Product Picture
Figure 5. Global Human Chorionic Gonadotropin (HCG) Market Share by Application in 2021 & 2028
Figure 6. Female Infertility Treatment
Figure 7. Oligospermic Treatment
Figure 8. Cryptorchidism Treatment
Figure 9. Others
Figure 10. Human Chorionic Gonadotropin (HCG) Report Years Considered
Figure 11. Global Human Chorionic Gonadotropin (HCG) Sales 2017-2028 (K Units)
Figure 12. Global Human Chorionic Gonadotropin (HCG) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Human Chorionic Gonadotropin (HCG) Revenue 2017-2028 (US$ Million)
Figure 14. Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2017-2022)
Figure 16. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2023-2028)
Figure 17. North America Human Chorionic Gonadotropin (HCG) Sales YoY (2017-2028) & (K Units)
Figure 18. North America Human Chorionic Gonadotropin (HCG) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Human Chorionic Gonadotropin (HCG) Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Human Chorionic Gonadotropin (HCG) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Human Chorionic Gonadotropin (HCG) Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Human Chorionic Gonadotropi
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs